Hvsen Biotechnology Co., Ltd.

SZSE:300871.SZ

14.16 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q3
Operating Activities:
Net Income 004.22-35.473-16.4061.903-1.0211.04214.85626.319.8934.4892.02413.13718.40137.87163.45753.21244.37927.24225.32433.1499.32
Depreciation & Amortization 00027.68727.68733.214-54.03127.12327.12362.69521.00810.33910.3399.6269.6265.1575.15719.082-9.3699.369012.0920
Deferred Income Tax 000000000000000-1.2580000000
Stock Based Compensation 0001.86700000-0.7640000.764000000000
Change In Working Capital 000-30.1690-137.87865.25-65.25043.923-2.8272.8270-65.909130.489-130.4890-249.68760.941-60.9410-7.2080
Accounts Receivables 00031.4690-109.8219.561-19.561014.4412.379-12.379021.69430.009-30.0090-195.01933.361-33.3610-37.1980
Change In Inventory 000-63.3770-28.05952.404-52.404030.42-6.8366.8360-105.917107.213-107.2130-55.82327.121-27.12108.850
Change In Accounts Payables 00000000000000000000000
Other Working Capital 0001.73900-6.7146.7140-0.937-8.378.37018.314-6.7336.73301.1550.459-0.459021.140
Other Non Cash Items 0035.58380.848-26.50273.45844.21962.88-59.159-108.8079.44524.184-7.35632.6751.04251.716-76.877182.478-74.73935.097-14.03829.964-9.32
Operating Cash Flow 0039.80317.688-42.90742.14854.41725.794-17.1823.34747.51841.84-16.02536.18159.81683.172-18.5765.08521.21210.76711.28667.9970
Investing Activities:
Investments In Property Plant And Equipment -38.18-26.02-51.418-37.607-79.38-41.238-37.137-45.523-60.413-104.346-91.667-96.049-136.802-104.807-252.75-153.44-89.125-76.138-88.316-40.01-26.38-53.879-28.942
Acquisitions Net 000.3870.310.08-0.0020.0020000.0400104.8040.105153.4489.125000000
Purchases Of Investments -185.45-84.852-221.031-90-180.404-200.151-190-215-380.3750-210-370-270-300-10-170000000
Sales Maturities Of Investments 95.784135.471207.214140180316.289168.379232.592352.2740191.929151.55830.3530.05342.191171.145411.485000000
Other Investing Activites 0.380.33-1.68352.4283.048116.1360-0-0155.43300.009-239.647-0.0030.105-153.440-439.597-88.3160.001-26.380.0010.046
Investing Cash Flow -127.46624.929-66.53112.703-79.70474.898-58.757-27.931-88.51451.087-109.698-314.482-376.449-134.756-210.4547.705152.36-515.734-88.316-40.01-26.38-53.878-28.896
Financing Activities:
Debt Repayment 35-19.936-113.2853.66806.549-67.366-8.97436.34-4.59368.467-3006.32268.3690-13-99.619.912.8618.45-10.55
Common Stock Issued 000000-3.313.3100-8.500-4.628000000000
Common Stock Repurchased 000-2.40-3.313.31-3.310-53.6778.5-8.500000000000
Dividends Paid -2.487-8.336-3.276-46.312-1.232-48.969-2.095-48.87-1.745-3.546-2.475-55.533-0.931-0.216-1.548-45.576-0.595-4.739-0.078-0.736-0.44-15.466-0.168
Other Financing Activities 3.84412.5988.05835.2116.436-1.048-13.66338.6293082.26-35.638-1.2432.306698.4165.879-3.342-4.622-7.402848.817-1.889-1.909-3.542-1.492
Financing Cash Flow 36.357-15.673-108.49842.25895.204-0.423-83.123-22.52664.59520.44438.854-95.2771.375704.52272.7-48.918-18.217-111.741868.6410.17458.652-10.558-12.042
Other Information:
Effect Of Forex Changes On Cash 0.404-0.4350.1350.042-0.356-0.233-0.0120.047-0.034-0.1310.044-0.0120.029-0.0150.004-0.0240.008-0.0380.006-0.0050.001-0.010.016
Net Change In Cash -32.74445.242-135.09164.73285.642110.101-90.854-27.208-41.13494.748-23.282-367.93-391.07605.879-80.12540.79114.09-622.429801.541-19.07443.5583.552-22.225
Cash At End Of Period 151.848184.592139.35350.8286.068229.512119.411210.265237.472278.606183.858207.14575.071966.141360.261440.387399.597285.507907.936106.395125.46881.9178.359